RDNZ’s feedback on the proposal to fund Trikafta for people wih cystic fibrosis
RDNZ provided feedback under Pharmac's consultation process on the proposal to fund Trikafta for people with cystic fibrosis (CF) aged 6 years and over from 1 April 2023.
Read the full submission here.